ArticleClinical pharmacology : advances and applications2018

Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin.

Felix Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.